In this study, we confirmed that RIOK1 and AKT1 levels significantly increased in GBM tissues and were positively associated with tumor malignancy, while knockdown of RIOK1 inhibits glioma cell growth through AKT1 and c-Myc in vitro. The gene discussed is MYC; the disease is central nervous system cancer.